Ipca Laboratories Limited (IPCALAB.BO)
INR 1363.95
(4.85%)
INR 1363.95
(4.85%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 24.71 Billion INR | 41.75% |
| 2022 | 17.43 Billion INR | -6.17% |
| 2021 | 18.57 Billion INR | 16.5% |
| 2020 | 15.94 Billion INR | 20.53% |
| 2019 | 13.23 Billion INR | 23.37% |
| 2018 | 10.72 Billion INR | 21.79% |
| 2017 | 8.8 Billion INR | -0.18% |
| 2016 | 8.82 Billion INR | 5.35% |
| 2015 | 8.37 Billion INR | -9.55% |
| 2014 | 9.25 Billion INR | 9.23% |
| 2013 | 8.47 Billion INR | 14.38% |
| 2012 | 7.41 Billion INR | 10.62% |
| 2011 | 6.69 Billion INR | 43.63% |
| 2010 | 4.66 Billion INR | 22.66% |
| 2009 | 3.8 Billion INR | 24.19% |
| 2008 | 3.06 Billion INR | 14.41% |
| 2007 | 2.67 Billion INR | 13.27% |
| 2006 | 2.36 Billion INR | 26.24% |
| 2005 | 1.87 Billion INR | 4.46% |
| 2004 | 1.79 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 24.71 Billion INR | 41.75% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 24.71 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 24.5 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 17.43 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 17.43 Billion INR | -6.17% |
| 2022 Q2 | 18.23 Billion INR | 0.0% |
| 2021 Q4 | 18.57 Billion INR | 0.0% |
| 2021 FY | 18.57 Billion INR | 16.5% |
| 2021 Q2 | 15.46 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 15.94 Billion INR | 20.53% |
| 2020 Q4 | 15.94 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 13.97 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 13.23 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 11.6 Billion INR | 0.0% |
| 2019 FY | 13.23 Billion INR | 23.37% |
| 2018 Q4 | 10.72 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2018 FY | 10.72 Billion INR | 21.79% |
| 2017 FY | 8.8 Billion INR | -0.18% |
| 2016 FY | 8.82 Billion INR | 5.35% |
| 2015 FY | 8.37 Billion INR | -9.55% |
| 2014 FY | 9.25 Billion INR | 9.23% |
| 2013 FY | 8.47 Billion INR | 14.38% |
| 2012 FY | 7.41 Billion INR | 10.62% |
| 2011 FY | 6.69 Billion INR | 43.63% |
| 2010 FY | 4.66 Billion INR | 22.66% |
| 2009 FY | 3.8 Billion INR | 24.19% |
| 2008 FY | 3.06 Billion INR | 14.41% |
| 2007 FY | 2.67 Billion INR | 13.27% |
| 2006 FY | 2.36 Billion INR | 26.24% |
| 2005 FY | 1.87 Billion INR | 4.46% |
| 2004 FY | 1.79 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -50.365% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 74.804% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -270.739% |
| Granules India Limited | 13 Billion INR | -90.021% |
| Indoco Remedies Limited | 3.53 Billion INR | -599.969% |
| Achyut Healthcare Limited | 568 Thousand INR | -4350797.887% |
| Ajanta Pharma Limited | 8.28 Billion INR | -198.338% |
| Alkem Laboratories Limited | 26.61 Billion INR | 7.135% |
| Alpa Laboratories Limited | 136.65 Million INR | -17984.565% |
| Brooks Laboratories Limited | 96.1 Million INR | -25613.884% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -984.469% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -1615.732% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -1986.422% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 61.114% |
| Eris Lifesciences Limited | 1.89 Billion INR | -1207.35% |
| FDC Limited | 3.88 Billion INR | -535.48% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 1.661% |
| Gufic Biosciences Limited | 2 Billion INR | -1132.684% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -23531.487% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -16378.696% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -25126.716% |
| Lasa Supergenerics Limited | 190.43 Million INR | -12877.252% |
| Laurus Labs Limited | 18.45 Billion INR | -33.917% |
| Lupin Limited | 49.53 Billion INR | 50.114% |
| Mankind Pharma Limited | 15.53 Billion INR | -59.084% |
| Medicamen Biotech Limited | 593.75 Million INR | -4062.192% |
| Medico Remedies Limited | 163.37 Million INR | -15026.888% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | -252.792% |
| Piramal Pharma Limited | 21.75 Billion INR | -13.577% |
| RPG Life Sciences Limited | 1.01 Billion INR | -2346.842% |
| Sigachi Industries Limited | 707.2 Million INR | -3394.465% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 74.957% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -968.926% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -11622.648% |
| Unichem Laboratories Limited | 7.04 Billion INR | -250.701% |
| Wanbury Limited | 360.23 Million INR | -6760.329% |
| Windlas Biotech Limited | 621.89 Million INR | -3873.87% |
| ZIM Laboratories Limited | 812.62 Million INR | -2941.129% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 28.199% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 22.383% |
| Hester Biosciences Limited | 755.81 Million INR | -3169.75% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -2164.971% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -8449.855% |
| Bal Pharma Limited | 878.11 Million INR | -2714.338% |
| Strides Pharma Science Limited | 11.26 Billion INR | -119.43% |
| Venus Remedies Limited | 1.21 Billion INR | -1930.824% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -284.424% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -248.488% |
| Shilpa Medicare Limited | 3.44 Billion INR | -616.471% |
| Aarti Drugs Limited | 4.85 Billion INR | -408.615% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -481.704% |
| Suven Life Sciences Limited | 7.08 Million INR | -348708.751% |
| Ind-Swift Limited | 640.91 Million INR | -3755.909% |
| Valiant Laboratories Limited | 100.15 Million INR | -24575.1% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -391.793% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -587.048% |
| Themis Medicare Limited | 705.74 Million INR | -3401.714% |
| Hikal Limited | 3.03 Billion INR | -713.68% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -8.438% |
| Sequent Scientific Limited | 3.46 Billion INR | -613.773% |
| Novartis India Limited | 448.6 Million INR | -5408.939% |
| Wockhardt Limited | 6.4 Billion INR | -286.142% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -91.634% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -96825.521% |
| Neuland Laboratories Limited | 3.5 Billion INR | -605.238% |
| Morepen Laboratories Limited | 2.48 Billion INR | -894.114% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -61868.656% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -1898.798% |